The Global market for Tissue regeneration is soaring high with an influencing growth rate above 15% per year through 2013. In 2008, U.S accounted for more than 85% of the worldwide market. Also the markets of Europe, Japan and other countries are exp ....see more
The Regenerative Medicine Market is expected to grow from USD 8.5 billion in 2020 to USD 17.9 billion by 2025, at a CAGR of 15.9% during the forecast period. The major players operating in this market are 3M (US), Allergan plc (Ireland), Amgen, Inc. (US), Aspect Biosystems (Canada), bluebird bio (US), Kite Pharma (US), Integra LifeSciences Holdings Corporation (US), MEDIPOST Co., Ltd. (South Korea), Medtronic plc (Ireland), Anterogen Co., Ltd. (South Korea), MiMedx Group (US), Misonix (US), Novartis AG (Switzerland), Organogenesis Inc. (US), Orthocell Limited (Australia), Corestem, Inc. (South Korea), Spark Therapeutics (US), APAC Biotech (India), Shenzhen Sibiono GeneTech Co., Ltd. (China), Smith & Nephew plc (UK), Stryker Corporation (US), Takeda Pharmaceutical Company Limited (Japan), Tego Science (South Korea), Vericel Corporation (US), and Zimmer Biomet (US).